The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage]2017 Available from http://goldcopd.org/Accessed January 10, 2017
   Google Scholar
• NewmanSPInhaler treatment options in COPDEur Respir Rev20051496102108
   Google Scholar
• LenneyJInnesJACromptonGKInappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICIRespir Med200094549650010868714
   PubMed Web of Science ®Google Scholar
• LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthma and COPDRespir Med2008102459360418083019
   PubMed Web of Science ®Google Scholar
• WesterikJACarterVChrystynHCharacteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care settingJ Asthma201653332132926810934
   PubMed Web of Science ®Google Scholar
• ChrystynHPriceDBMolimardMComparison of serious inhaler technique errors made by device-naive patients using three different dry powder inhalers: a randomised, crossover, open-label studyBMC Pulm Med2016161226769482
   PubMed Web of Science ®Google Scholar
• MiravitllesMVogelmeierCRocheNA review of national guidelines for management of COPD in EuropeEur Respir J201647262563726797035
   PubMed Web of Science ®Google Scholar
• LatorreMNovelliFVagagginiBDifferences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): role of ICSPulm Pharmacol Ther201530445025445928
   PubMed Web of Science ®Google Scholar
• Accuhaler® SSeretide DPI Summary of Product Characteristics2015 Available from https://www.medicines.org.uk/emc/medicine/2317Accessed November 22, 2016
   Google Scholar
• Evohaler® SSeretide MDI Summary of Product Characteristics2015 Available from https://www.medicines.org.uk/emc/medicine/2914Accessed November 22, 2016
   Google Scholar
• GaoJPleasantsRARole of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPDInt J Chron Obstruct Pulmon Dis20151077578925926729
   PubMed Web of Science ®Google Scholar
• BrennanPOInhaled salbutamol: a new form of drug abuse?Lancet19832835710301031
   Web of Science ®Google Scholar
• EdwardsJGHolgateSTDependency upon salbutamol inhalersBr J Psychiatry1979134624626486238
   PubMed Web of Science ®Google Scholar
• PrattHFAbuse of salbutamol inhalers in young peopleClin Allergy19821222032097074823
   PubMedGoogle Scholar
• ThompsonPJDhillonPColePAddiction to aerosol treatment: the asthmatic alternative to glue sniffingBr Med J (Clin Res Ed)1983287640415151516
   Web of Science ®Google Scholar
• BoydGMoriceAHPounsfordJCSiebertMPeslisNCrawfordCAn evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)Eur Respir J19971048158219150318
   PubMed Web of Science ®Google Scholar
• JonesPWBoshTKQuality of life changes in COPD patients treated with salmeterolAm J Respir Crit Care Med19971554128312899105068
   PubMed Web of Science ®Google Scholar
• BurgePSEUROSCOP, ISOLDE and the Copenhagen city lung studyThorax199954428728810092687
   PubMed Web of Science ®Google Scholar
• HananiaNADarkenPHorstmanDThe efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPDChest2003124383484312970006
   PubMed Web of Science ®Google Scholar
• KoserAWestermanJSharmaSEmmettACraterGDSafety and efficacy of fluticasone propionate/salmeterol hydrofluoroalkane 134a metered-dose-inhaler compared with fluticasone propionate/salmeterol diskus in patients with chronic obstructive pulmonary diseaseOpen Respir Med J20104869121253451
   PubMedGoogle Scholar
• PriceDRocheNChristian VirchowJDevice type and real-world effectiveness of asthma combination therapy: an observational studyRespir Med2011105101457146621612903
   PubMed Web of Science ®Google Scholar
• OPCRDThe Optimum Patient Care Research Database (OPCRD)2016 Available from http://optimumpatientcare.org/opcrd/Accessed 2016
   Google Scholar
• RocheNReddelHMartinRQuality standards for real-world research. Focus on observational database studies of comparative effectivenessAnn Am Thorac Soc201411Suppl 2S99S10424559028
   PubMedGoogle Scholar
• StuartEAMatching methods for causal inference: a review and a look forwardStat Sci201025112120871802
   PubMed Web of Science ®Google Scholar
• van AalderenWMGriggJGuilbertTWSmall-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthmaJ Allergy Clin Immunol Pract201535721731.e1626032474
   PubMed Web of Science ®Google Scholar
• GSKADVAIR DISKUS^® 250/202017 Available from https://www.gsksource.com/advair_diskusAccessed January 19, 2017
   Google Scholar
• CalverleyPPauwelsRVestboJCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trialLancet2003361935644945612583942
   PubMed Web of Science ®Google Scholar
• CalverleyPMStockleyRASeemungalTAReported pneumonia in patients with COPD: findings from the INSPIRE studyChest2011139350551220576732
   PubMed Web of Science ®Google Scholar
• AnzuetoAFergusonGTFeldmanGEffect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomesCOPD20096532032919863361
   PubMedGoogle Scholar
• FergusonGTAnzuetoAFeiREmmettAKnobilKKalbergCEffect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbationsRespir Med200810281099110818614347
   PubMed Web of Science ®Google Scholar
• HaughneyJPriceDBarnesNCVirchowJCRocheNChrystynHChoosing inhaler devices for people with asthma: current knowledge and outstanding research needsRespir Med201010491237124520472415
   PubMed Web of Science ®Google Scholar
• JanssensWVandenBrandePHardemanEInspiratory flow rates at different levels of resistance in elderly COPD patientsEur Respir J2008311788317898020
   PubMed Web of Science ®Google Scholar
• ChenRChenRChenXChenLEffect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary diseaseIntern Med J201444879180024860934
   PubMed Web of Science ®Google Scholar
• LohCHPetersSPLovingsTMOharJASuboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all cause readmissionsAnn Am Thorac Soc2017
   Web of Science ®Google Scholar
• MolimardMRaherisonCLignotSChronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patientsEur Respir J2017492pii 1601794
   Web of Science ®Google Scholar
• GiraudVAllaertFARocheNInhaler technique and asthma: feasability and acceptability of training by pharmacistsRespir Med2011105121815182221802271
   PubMed Web of Science ®Google Scholar
• Bosnic-AnticevichSChrystynHCostelloRWThe use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomesInt J Chron Obstruct Pulmon Dis201712597128053517
   PubMed Web of Science ®Google Scholar
• PostmaDSRocheNColiceGComparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPDInt J Chron Obstruct Pulmon Dis201491163118625378918
   PubMed Web of Science ®Google Scholar
• MartinRJSzeflerSJChinchilliVMSystemic effect comparisons of six inhaled corticosteroid preparationsAm J Respir Crit Care Med2002165101377138312016099
   PubMed Web of Science ®Google Scholar
• DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
   PubMed Web of Science ®Google Scholar
• GuilbertTWColiceGGriggJReal-Life outcomes for patients with asthma prescribed spacers for use with either extrafine-or fine-particle inhaled corticosteroidsJ Allergy Clin Immunol Pract2017
   Web of Science ®Google Scholar
• BorgstromLAskingLLipniunasPAn in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditionsJ Aerosol Med200518330431016181005
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence (NICE)Chronic obstructive pulmonary disease Available from: https://www.nice.org.uk/guidance/conditions-and-diseases/respiratory-conditions/chronic-obstructive-pulmonary-diseaseAccessed July 18, 2017
   Google Scholar
• PriceDBRussellRMaresRMetabolic effects associated with ICS in patients with COPD and comorbid type 2 diabetes: a historical matched cohort studyPLoS One2016119e016290327658209
   PubMed Web of Science ®Google Scholar
• SuissaSKezouhAErnstPInhaled corticosteroids and the risks of diabetes onset and progressionAm J Med2010123111001100620870201
   PubMed Web of Science ®Google Scholar
• DrummondMBDasenbrookECPitzMWMurphyDJFanEInhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysisJAMA2008300202407241619033591
   PubMed Web of Science ®Google Scholar
• SinghSAminAVLokeYKLong-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysisArch Intern Med2009169321922919204211
   PubMed Web of Science ®Google Scholar
• CrimCCalverleyPMAndersonJAPneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsEur Respir J200934364164719443528
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• MapelDSchumMYoodMBrownJMillerDDavisKPneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilatorsPrim Care Respir J201019210911720082059
   PubMedGoogle Scholar
• WedzichaJACalverleyPMSeemungalTAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for Diagnosis, Management, and Prevention of COPD – 2016 Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Accessed July 18, 2017
   Google Scholar